A previous report showed that patients with severe COVID-19 have higher plasma levels of MMP-7 after short-term follow-up (median 9 weeks), displaying an inverse correlation with forced vital capacity (FVC) and diffusing capacity for carbon monoxide (DLCO) [11]. This evidence concerns the gene MMP7 and COVID-19.